These data suggest that, while IDH mutation status may be a marker for worse prognosis in the already highly aggressive dedifferentiated subsets, it does not support the predictive nature of IDH mutation status alone in conventional chondrosarcoma. This evidence concerns the gene IDH1 and chondrosarcoma.